000			01449 a2200433 4500
005			20250513214109.0
264		0	_c20000928
008			200009s 0 0 eng d
022			_a0020-7136
040			_aNLM _beng _cNLM
100	1		_aNaimi, B
245	0	0	_aNo evidence for fibroblast growth factor receptor 3 (FGFR-3) R248C/S249C mutations in human prostate cancer. _h[electronic resource]
260			_bInternational journal of cancer _cAug 2000
300			_a455-6 p. _bdigital
500			_aPublication Type: Letter
650	0	4	_aAdenocarcinoma _xgenetics
650	0	4	_aDNA Mutational Analysis
650	0	4	_aDNA, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMultiple Myeloma _xepidemiology
650	0	4	_aMutation, Missense
650	0	4	_aOrgan Specificity
650	0	4	_aPoint Mutation
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aProstatic Neoplasms _xgenetics
650	0	4	_aProtein-Tyrosine Kinases
650	0	4	_aReceptor, Fibroblast Growth Factor, Type 3
650	0	4	_aReceptors, Fibroblast Growth Factor _xgenetics
650	0	4	_aUrinary Bladder Neoplasms _xgenetics
650	0	4	_aUterine Cervical Neoplasms _xgenetics
700	1		_aLatil, A
700	1		_aBerthon, P
700	1		_aCussenot, O
773	0		_tInternational journal of cancer _gvol. 87 _gno. 3 _gp. 455-6
999			_c10847438 _d10847438